Israel Englander Catalyst Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 430,130 shares of CPRX stock, worth $8.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
430,130
Previous 303,533
41.71%
Holding current value
$8.75 Million
Previous $7.36 Million
26.81%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CPRX
# of Institutions
384Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$380 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$111 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.1 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...